EnGene Holdings Net Income From Continuing Ops Over Time
| ENGNW Stock | 0.86 0.11 14.67% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out EnGene Holdings Performance and EnGene Holdings Correlation. EnGene |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnGene Holdings. If investors know EnGene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnGene Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of enGene Holdings Warrants is measured differently than its book value, which is the value of EnGene that is recorded on the company's balance sheet. Investors also form their own opinion of EnGene Holdings' value that differs from its market value or its book value, called intrinsic value, which is EnGene Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnGene Holdings' market value can be influenced by many factors that don't directly affect EnGene Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnGene Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if EnGene Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnGene Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income From Continuing Ops Analysis
Compare enGene Holdings Warrants and related stocks such as Tandem Diabetes Care, Boyd Gaming, and Sonida Senior Living Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TNDM | (79.5 M) | (79.5 M) | (79.5 M) | (79.5 M) | (79.5 M) | (72.4 M) | (83.4 M) | (73 M) | (122.6 M) | (24.8 M) | (34.4 M) | 15.6 M | (94.6 M) | (222.6 M) | (200.3 M) | (190.3 M) |
| BYD | (8 M) | (8 M) | (923.1 M) | (119.3 M) | (41.6 M) | 47.2 M | 205.5 M | 167.8 M | 114.7 M | 157.6 M | (134.7 M) | 463.8 M | 639.4 M | 700.1 M | 805.1 M | 845.4 M |
| SNDA | (44.2 M) | (44.2 M) | (44.2 M) | (44.2 M) | (44.2 M) | (44.2 M) | (44.2 M) | (44.2 M) | (53.6 M) | (36 M) | (295.4 M) | 125.6 M | (54.4 M) | (23.1 M) | (26.5 M) | (27.8 M) |
| BILI | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (2.1 M) | (911.5 M) | (183.8 M) | (565 M) | (1.3 B) | (3.1 B) | (6.8 B) | (7.5 B) | (4.8 B) | (4.3 B) | (4.5 B) |
| TFX | 125.9 M | 121.7 M | (181.8 M) | 152.2 M | 191.5 M | 236.8 M | 237.7 M | 155.3 M | 196.4 M | 462 M | 335.8 M | 485.1 M | 362.9 M | 357.6 M | 411.2 M | 254.5 M |
enGene Holdings Warrants and related stocks such as Tandem Diabetes Care, Boyd Gaming, and Sonida Senior Living Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| enGene Holdings Warrants | ENGNW |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Quebec; Canada |
| Exchange | NASDAQ Exchange |
null 0.86
Additional Tools for EnGene Stock Analysis
When running EnGene Holdings' price analysis, check to measure EnGene Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnGene Holdings is operating at the current time. Most of EnGene Holdings' value examination focuses on studying past and present price action to predict the probability of EnGene Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnGene Holdings' price. Additionally, you may evaluate how the addition of EnGene Holdings to your portfolios can decrease your overall portfolio volatility.